Skip to content
CTVACorteva

What Is CTVA Fair Value?

Corteva (CTVA) fair value estimate using multiple valuation models, updated daily.

As of August 29, 2026, Corteva (CTVA) has a composite fair value estimate of $82.03 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $83.90, suggesting the stock is fair value by 2.2%.

Data as of August 29, 2026 (today)

Composite Fair Value

Fair Value4 of 4 models

$82.03

vs. current price of $83.90(-2.2%)

Undervalued$82.03Overvalued
$83.90

How Is CTVA Fair Value Calculated?

Four independent models estimate what CTVA is worth. Each uses different inputs and assumptions. The composite blends them by weight.

CTVA Intrinsic Value

Forward-looking models based on future cash flows

DCF (Discounted Cash Flow)

35% weight

Estimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →

$126.28

+50.5%

Undervalued

Inputs used

FCF: 2.4BGrowth: 11.1%Discount: 7%

DDM (Dividend Discount Model)

15% weight

If a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →

$36.46

-56.5%

Overvalued

Inputs used

Dividend: $0.72/yrReq. Return: 8%Growth: 5.5%

CTVA Fair Value

Current fundamentals: earnings, assets, and growth rate

Graham Number (Value Investing)

25% weight

Created by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →

$56.52

-32.6%

Overvalued

Inputs used

EPS: $3.76Book Value: $37.72

PEG (Price/Earnings to Growth)

25% weight

Checks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.

$41.74

-50.2%

Overvalued

Inputs used

EPS: $3.76Growth: 11.1%

What If You Change the Assumptions?

Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.

Your DCF Fair Value

$126.28Undervalued

Current price $83.90 is 50.5% below this estimate

CheapFair ValueExpensive
11.1%
0.0%30.0%
7.3%
6.0%15.0%
2.5%
1.0%4.0%
15.0%
0.0%50.0%
View 10-year cash flow projections
YearProjected FCF (Free Cash Flow)Present Value
Year 1$2.69B$2.50B
Year 2$2.98B$2.59B
Year 3$3.31B$2.68B
Year 4$3.68B$2.77B
Year 5$4.09B$2.87B
Year 6$4.54B$2.97B
Year 7$5.05B$3.08B
Year 8$5.61B$3.18B
Year 9$6.23B$3.29B
Year 10$6.92B$3.41B
Terminal Value$146.70B$72.28B

What Are CTVA's Key Financial Metrics?

Earnings & Growth

Current Price

$83.90

EPS (TTM)

$1.65

Forward P/E

20.4

Profit Margin

5.7%

Cash & Balance Sheet

Free Cash Flow

2.4B

EBITDA

4.3B

Book Value

$37.72

Total Debt

4.9B

What Do Analysts Say About CTVA?

Low

$78.00

Average

$92.10

High

$103.00

Upside

+9.8%

Current $83.90Avg Target $92.10Buy20 analysts

CTVA Fair Value FAQ

What is the fair value of CTVA?

Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), CTVA's estimated fair value is $82.03. The stock is currently trading at $83.90, which makes it fair value by our analysis.

How is CTVA's fair value calculated?

We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.

Is CTVA overvalued or undervalued?

Based on our analysis, CTVA is fair value. The current price of $83.90 is 2.2% above our estimated fair value of $82.03.

What do Wall Street analysts say about CTVA?

20 analysts cover Corteva with a consensus rating of "Buy." The average price target is $92.10, ranging from $78.00 to $103.00. This implies 9.8% upside from the current price.